Tommasa Vicario

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department.

The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department.

Journal: Journal of thrombosis and thrombolysis

Published: March 25, 2025

Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency department.

Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency department.

Journal: Internal and emergency medicine

Published: March 12, 2022

Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment.

Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment.

Journal: Progress in cardiovascular diseases

Published: April 21, 2021

Features of severe COVID-19: A systematic review and meta-analysis.

Features of severe COVID-19: A systematic review and meta-analysis.

Journal: European journal of clinical investigation

Published: June 30, 2020

Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality".

Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality".

Journal: Atherosclerosis

Published: November 08, 2016

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.

Journal: Pharmacological research

Published: August 30, 2016

Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".

Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".

Journal: International journal of cardiology

Published: October 07, 2015

Antiphospholipid syndrome and anticoagulation quality: a clinical challenge.

Antiphospholipid syndrome and anticoagulation quality: a clinical challenge.

Journal: Atherosclerosis

Published: July 25, 2015

Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".

Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".

Journal: International journal of cardiology

Published: April 13, 2015

Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation?

Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation?

Journal: Antioxidants & redox signaling

Published: April 01, 2015

Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.

Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.

Journal: International journal of cardiology

Published: February 23, 2015

Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists.

Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 30, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026